4th Quarter - Report

TIBER CREEK GROUP for ASTRAZENECA

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); Issues relating to Medicare Part D and Part B Pricing Reform; Issues relating to the Medicaid Drug Rebate Program (MDRP); H.R. 5539/S. 3131 - ORPHAN Cures Act.

LobbyistCovered position, as disclosed
JONATHON JONES —
COREY MALMGREN —
TIMOTHY ROBINSON —
JOHN KIRKLAND TWOMEY —
DANIEL HOWARD ZAWITOSKI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 3131 (118th), H.R. 5539 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.